SPAMPINATO, SANTI MARIO
SPAMPINATO, SANTI MARIO
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di Ia fascia
SANTI SPAMPINATO; Spampinato S; Santi M Spampinato; S.M. SPAMPINATO; Spampinato SM; S.SPAMPINATO
β-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonist
2010 Spartà A; Baiula M; Campbell G; Spampinato S.
β-Endorphin in pressor response to hyperventilation in elderly patients with essential and secondary hypertension
2008 F. Fontana; P. Bernardi; C. Pizzi; R. Di Toro; S. Spampinato
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists
2015 De Marco, Rossella; Mazzotti, Giacomo; Dattoli, Samantha D.; Baiula, Monica; Spampinato, Santi; Greco, Arianna; Gentilucci, Luca
A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin
2016 Strack, Martin; Bedini, Andrea; Yip, King T.; Lombardi, Sara; Siegmund, Daniel; Stoll, Raphael; Spampinato, Santi M.; Metzler-Nolte, Nils
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics
2012 R. De Marco; A. Tolomelli; A. Bedini; S. Spampinato; L. Gentilucci
A novel family of minimalist opioid peptides deprived of the classic pharmacophores
2011 L. Gentilucci; R. de Marco; A. Tolomelli; S. Feddersen; S. Spampinato; A. Bedini; R. Artali
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES
2010 L. Gentilucci; R. De Marco; A. Tolomelli; S. Spampinato; A. Bedini; R. Artali
Administration of antisense oligonucleotide against pro-opiomelanocortin prevents enduring hormonal alterations induced by neonatal handling in male mice.
2006 GALIETTA G;LOIZZO A; LOIZZO S;TROMBETTA G ;SPAMPINATO S;CAMPANA G;CAPASSO A;PALERMO M; GUARINO I; FRANCONI F.
Agonist binding properties for recombinant kappa opioid receptors expressed in CHO-K1 cells
1997 Carboni L.; Campana G.; Cacciaguerra S.; Murari G.; Speroni E.; Pappalardo M.S.; Ronsisvalle G.; Spampinato S.
Agonist-regulated endocytosis and desensitization of the human nociceptin receptor
2006 Spampinato S.; Baiula M.
Agonist-Regulated Internalization and desensitization of the Human Nociceptin Receptor Expressed in CHO Cells
2007 Spampinato S.; Baiula M.; Calienni M.
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines
2001 Budriesi R.; Cacciaguerra S.; Di Toro R.; Bolognesi M.L.; Chiarini A.; Minarini A.; Rosini M.; Spampinato S.; Tumiatti V.; Melchiorre C.
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics
2010 L. Gentilucci; G. Cardillo; S. Spampinato; A. Tolomelli; F. Squassabia; R. De Marco; A. Bedini; M. Baiula; L. Belvisi; M. Civera
Antisense versus proopiomelanocortin mRNA reduces vascular risk in a murine model of type-2 diabetes following stress exposure in early post-natal life.
2015 Loizzo A; Spampinato SM; Fortuna A; Vella S; Fabi F; Del Basso P; Campana G; Loizzo S.
Attività calcio modulatrice a livello cardiaco e vasale di derivati imidazo[2,1-b]tiazolici
2006 Locatelli A.; Budriesi R.; Di Toro R.; Ioan P.; Leoni A.; Ugenti M.P.; Andreani A.; Spampinato S.; Chiarini A.
Biphasic modulation of mu-opoid receptor (MOR) transcription by nociceptin in neuroblastoma cells co-expressing MOR and NOP receptors
2010 Bedini A.; Spampinato S.
BNP in normotesi ed ipertesi con sospetta insufficienza coronarica sottoposti a scintigrafia miocardica con adenosina
2007 F. Fontana; P. Bernardi; C. Pizzi; R. Di Toro; S. Spampinato
Brain-body metabolic programming and functional derangement in a type-2 diabetes model in male mice: the role exerted by opioid and HPA systems.
2009 S.LOIZZO; G. CAMPANA; S. SPAMPINATO; A. CAPASSO; A. FORTUNA; F. FRANCONI; P. RENZI; A. LOIZZO.
Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells
1993 Spampinato S.; Bachetti T.; Carboni L.; Ratti E.; Van Amsterdam F.Th.M.; Ferri S.
CCB, a novel specific κ opioid agonist, which discriminates between opioid and σ1 recognition sites
1995 Ronsisvalle G.; Prezzavento O.; Pasquinucci L.; Marrazzo A.; Vittorio F.; Gomez-Vidal J.A.; Carboni L.; Spampinato S.